| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |